All News - Eli Lilly and Company
WEBSeptember 13, 2024. Lilly expands manufacturing footprint in Ireland with $1.8 billion investment. September 12, 2024. With once-a-week dosing, insulin efsitora alfa delivers similar A1C reduction compared to daily insulin in …
Lilly.com | Eli Lilly and Company
WEBSep 13, 2024 · Press Releases. ALL CORPORATE FINANCIAL PRODUCT IMPACT ARCHIVE. New data show Lilly's EBGLYSS™ (lebrikizumab-lbkz) provided sustained disease control for up to three years in more than 80% of adults and adolescents with moderate-to-severe atopic dermatitis. September 25, 2024. Tags | Product.
News Release - Eli Lilly and Company
WEBINDIANAPOLIS, April 17, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results of the SURMOUNT-OSA phase 3 clinical trials that showed tirzepatide injection (10 mg or 15 mg) significantly reduced the apnea-hypopnea index (AHI) compared to placebo, achieving the primary endpoints. Percentage change in …
News Release - Eli Lilly and Company
WEBJul 8, 2024 · INDIANAPOLIS and WALTHAM, Mass., July 8, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Morphic Holding, Inc. (NASDAQ: MORF) today announced a definitive agreement for Lilly to acquire Morphic, a biopharmaceutical company developing oral integrin therapies for treatment of serious chronic diseases.
Lilly.com | Eli Lilly and Company
WEBSep 4, 2024 · INDIANAPOLIS , June 25, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced a collaboration with OpenAI that will allow Lilly to leverage OpenAI 's generative AI to invent novel antimicrobials to treat drug-resistant pathogens. Antimicrobial resistance (AMR) is one of the top public.
Eli Lilly & Co: Strong Buy Rating Amid Robust Product Growth and ...
WEB1 day ago · Chris Schott has given his Buy rating due to a combination of factors including the expected significant growth of Eli Lilly & Co’s (LLY) products and the company’s strong pipeline.
Eli Lilly (LLY) earnings Q2 2024 - CNBC
WEBAug 8, 2024 · Eli Lilly reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3 billion as sales of its blockbuster diabetes drug Mounjaro and...
Lilly hits record high after Mounjaro fuels forecast raise, rival data
WEBAug 8 (Reuters) - Eli Lilly (LLY.N) on Tuesday raised its annual forecasts as demand for new diabetes drug Mounjaro surges ahead of a decision on its use as a weight-loss treatment, with shares...
News Release - Eli Lilly and Company
WEBINDIANAPOLIS, May 24, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it has more than doubled its investment in its Lebanon, Indiana, manufacturing site with a new $5.3 billion commitment, increasing the company's total investment in this site from $3.7 billion to $9 billion.
Lilly drug slows Alzheimer's by 35%, bolstering treatment approach
WEBCHICAGO, May 3 (Reuters) - An experimental Alzheimer's drug developed by Eli Lilly and Co (LLY.N) slowed cognitive decline by 35% in a late-stage trial, the company said on Wednesday,...